Get the Stockscreener App
50.52
0.06%
-0.03
After Hours:
50.46
-0.06
-0.12%
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Forecast
The Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $63.21, representing a +25.11% increase from the current price of $50.52. The highest analyst price target is $68.37, and the lowest is $58.04.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BIB Price Target
Average 63.63
(+25.96% Upside)
Is Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.11 | Neutral |
| STOCH(9,6) | 31.12 | Neutral |
| STOCHRSI(14) | 77.65 | Neutral |
| MACD(12,26) | -1.5116 | Buy |
| ADX(14) | 25.78 | Sell |
| William %R | -61.99 | Neutral |
| CCI(14) | -18.43 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
51.04
Sell
|
50.89
Sell
|
| MA20 |
51.23
Sell
|
51.90
Sell
|
| MA50 |
55.74
Sell
|
54.96
Sell
|
| MA100 |
59.90
Sell
|
57.50
Sell
|
| MA200 |
59.30
Sell
|
57.80
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BIB could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on BIB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.11 indicates that BIB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 31.12 indicates that BIB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.65 indicates that BIB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.78 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -18.43 indicates that BIB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BIB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Proshares Ultra Nasdaq Biotechnology 2 X Shares financial reports and earnings history, Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) stock could reach $57.10 by 2030, $71.95 by 2040 and $84.81 by 2050. See the projected annual prices until 2050 of the Proshares Ultra Nasdaq Biotechnology 2 X Shares stock below:
- Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) is expected to reach an average price of $53.33 in 2035, with a high prediction of $55.67 and a low estimate of $49.34. This indicates an $5.56% rise from the last recorded price of $50.52.
- Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) stock is projected to chart a bullish course in 2040, with an average price target of $69.30, representing an $37.17% surge from its current level. The forecast ranges from a conservative $67.06 to a sky-high $71.95.
- Our analysts predict Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) to jump 32.28% by 2045, soaring from $62.40 to an average price of $66.83, potentially reaching $74.96. While $62.40 is the low estimate, the potential upside is significant.
- Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) stock is expected to climb by 2050, reaching an average of $84.63, a $67.52% jump from its current level. However, a wide range of estimates exists, with high and low targets of $84.81 and $73.89, respectively, highlighting the market's uncertainty.
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Year by Year Forecast
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2025
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) is expected to reach an average price of $63.63 in 2025, with a high prediction of $87.43 and a low estimate of $39.84. This indicates an +25.96% rise from the last recorded price of $50.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $58.91 | $58.04 | $68.37 | +16.62% |
| March, 2025 | $56.59 | $54.80 | $68.99 | +12.01% |
| April, 2025 | $50.07 | $39.84 | $66.32 | -0.90% |
| May, 2025 | $67.26 | $46.40 | $69.33 | +33.14% |
| June, 2025 | $72.72 | $60.54 | $76.81 | +43.94% |
| July, 2025 | $78.26 | $65.34 | $78.40 | +54.91% |
| August, 2025 | $79.43 | $73.67 | $82.86 | +57.22% |
| September, 2025 | $75.89 | $72.34 | $87.43 | +50.22% |
| October, 2025 | $68.58 | $65.19 | $76.17 | +35.75% |
| November, 2025 | $74.34 | $65.53 | $77.13 | +47.16% |
| December, 2025 | $69.09 | $67.42 | $84.17 | +36.76% |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2026
The predicted value for Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) in 2026 is set at an average of $92.16. Estimates vary from a peak of $117.47 to a trough of $66.84, indicating an +82.42% surge from the present price of $50.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $81.75 | $66.84 | $81.84 | +61.81% |
| February, 2026 | $95.66 | $81.38 | $96.31 | +89.35% |
| March, 2026 | $102.31 | $87.31 | $104.66 | +102.51% |
| April, 2026 | $107.54 | $99.41 | $117.47 | +112.87% |
| May, 2026 | $94.29 | $79.84 | $106.41 | +86.64% |
| June, 2026 | $85.99 | $82.02 | $97.57 | +70.22% |
| July, 2026 | $86.54 | $79.59 | $97.99 | +71.30% |
| August, 2026 | $100.44 | $84.71 | $102.47 | +98.82% |
| September, 2026 | $101.16 | $93.74 | $105.66 | +100.24% |
| October, 2026 | $109.57 | $93.66 | $112.88 | +116.88% |
| November, 2026 | $109.61 | $99.56 | $116.45 | +116.97% |
| December, 2026 | $99.23 | $98.60 | $114.05 | +96.41% |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) is $73.05, with a high forecast of $103.17 and a low forecast of $42.93. This indicates an +44.60% increase from the last price of $50.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $93.62 | $90.09 | $97.87 | +85.32% |
| February, 2027 | $89.69 | $88.25 | $103.17 | +77.53% |
| March, 2027 | $88.91 | $76.87 | $92.47 | +76.00% |
| April, 2027 | $74.08 | $70.73 | $89.66 | +46.63% |
| May, 2027 | $65.00 | $58.87 | $72.60 | +28.65% |
| June, 2027 | $58.64 | $55.30 | $70.20 | +16.08% |
| July, 2027 | $66.53 | $55.92 | $69.24 | +31.68% |
| August, 2027 | $60.19 | $60.02 | $71.81 | +19.14% |
| September, 2027 | $54.73 | $43.83 | $61.62 | +8.33% |
| October, 2027 | $47.03 | $42.93 | $54.86 | -6.90% |
| November, 2027 | $60.71 | $47.78 | $61.07 | +20.17% |
| December, 2027 | $64.88 | $54.55 | $66.78 | +28.41% |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2028
In 2028, Proshares Ultra Nasdaq Biotechnology 2 X Shares (BIB) is projected to reach an average price of $58.73, with a high projection of $68.66 and a low estimate of $48.80. This indicates an +16.25% rise from the last price of $50.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $55.18 | $53.98 | $66.98 | +9.22% |
| February, 2028 | $52.19 | $48.80 | $61.41 | +3.30% |
| March, 2028 | $60.42 | $51.30 | $61.48 | +19.60% |
| April, 2028 | $64.14 | $57.54 | $66.51 | +26.95% |
| May, 2028 | $62.81 | $60.94 | $68.66 | +24.33% |
| June, 2028 | $65.26 | $59.29 | $68.06 | +29.17% |
| July, 2028 | $62.11 | $60.83 | $67.47 | +22.95% |
| August, 2028 | $53.01 | $52.18 | $63.95 | +4.93% |
| September, 2028 | $60.48 | $53.57 | $60.68 | +19.71% |
| October, 2028 | $61.93 | $57.90 | $62.80 | +22.59% |
| November, 2028 | $58.91 | $55.66 | $62.01 | +16.60% |
| December, 2028 | $56.61 | $55.09 | $61.93 | +12.06% |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2029
The 2029 price forecast for Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) is $55.91 on average, with a high prediction of $67.09 and a low estimate of $44.72. This represents an +10.66% increase from the previous price of $50.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $57.60 | $54.03 | $59.27 | +14.01% |
| February, 2029 | $56.34 | $54.35 | $57.86 | +11.53% |
| March, 2029 | $55.45 | $55.17 | $58.50 | +9.76% |
| April, 2029 | $52.09 | $49.82 | $55.26 | +3.12% |
| May, 2029 | $46.36 | $44.72 | $53.09 | -8.23% |
| June, 2029 | $51.12 | $45.32 | $51.12 | +1.19% |
| July, 2029 | $61.68 | $50.70 | $63.52 | +22.09% |
| August, 2029 | $61.75 | $60.66 | $66.00 | +22.22% |
| September, 2029 | $64.09 | $58.85 | $64.73 | +26.87% |
| October, 2029 | $61.08 | $59.34 | $67.09 | +20.90% |
| November, 2029 | $52.85 | $51.85 | $63.07 | +4.62% |
| December, 2029 | $56.86 | $52.64 | $60.75 | +12.55% |
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) Price Forecast for 2030
Proshares Ultra Nasdaq Biotechnology 2 X Shares Stock (BIB) is expected to reach an average price of $58.90 in 2030, with a high forecast of $73.61 and a low forecast of $44.18. This signifies an +16.58% surge from the last price of $50.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $55.14 | $52.17 | $57.10 | +9.15% |
| February, 2030 | $56.98 | $54.84 | $62.08 | +12.79% |
| March, 2030 | $56.42 | $55.59 | $59.19 | +11.68% |
| April, 2030 | $53.96 | $53.22 | $57.60 | +6.82% |
| May, 2030 | $51.27 | $50.50 | $56.79 | +1.48% |
| June, 2030 | $56.28 | $48.27 | $57.83 | +11.40% |
| July, 2030 | $65.24 | $56.42 | $65.44 | +29.14% |
| August, 2030 | $71.87 | $66.40 | $71.89 | +42.26% |
| September, 2030 | $70.25 | $66.75 | $73.61 | +39.06% |
| October, 2030 | $71.90 | $62.38 | $73.10 | +42.33% |
| November, 2030 | $50.68 | $45.99 | $73.33 | +0.32% |
| December, 2030 | $52.95 | $44.18 | $56.10 | +4.82% |
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):